New Biotie shares and increase of share capital registered with the
trade register

(Thomson Reuters ONE) - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 14 DECEMBER 2009 at11.00 a.m.New Biotie shares and increase of share capital registered with thetrade registerA total of 14,432,000 new shares subscribed by Invesco Fund ManagersLimited on 7 December 2009 in connection with Biotie TherapiesCorp.'s ("Biotie") directed share issue and the related increase ofBiotie's share capital by EUR 7,216,000 were registered with theTrade Register on 14 December 2009.The registered new shares together with the existing Biotie sharesare traded on NASDAQ OMX Helsinki Ltd as of 14 December 2009.The new shares entitle to the exercise of the rights belonging to ashareholder as of the registration date of 14 December 2009.After the registration of the new shares and the increase of theshare capital with the Finnish Trade Register the share capital inBiotie is EUR 51,506,678.10, the total number of shares is158,752,560 and the number of votes 158,289,305.In Turku, 14 December 2009Biotie Therapies Corp.Timo Veromaa, President and CEOFor further information, please contact:Virve Nurmi, Biotie Therapies Corp.tel. +358 2 274 8900, e-mail: virve.nurmi(at)biotie.comwww.biotie.comDISTRIBUTION:NASDAQ OMX Helsinki LtdMain MediaThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 14.12.2009 - 10:01 Uhr
Sprache: Deutsch
News-ID 9584
Anzahl Zeichen: 0

contact information:
Town:

London

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 461 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"New Biotie shares and increase of share capital registered with the
trade register"
steht unter der journalistisch-redaktionellen Verantwortung von

Biotie Therapies Oyj (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Biotie Announces Start of Clinical Study With Nepicastat (SYN117) in Cocaine Dep ...

TURKU, FINLAND -- (Marketwired) -- 05/10/13 -- BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 10 May 2013 at 9.00 a.m.Biotie Therapies today announced the start of a Phase 2 clinical study evaluating nepicastat (SYN117) in cocaine dependence. The Nat ...

Biotie: Selincro Launched in the United Kingdom ...

TURKU, FINLAND -- (Marketwired) -- 05/06/13 -- Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the United Kingdom. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, B ...

Biotie: Selincro Launched in First European Markets ...

TURKU, FINLAND -- (Marketwired) -- 04/22/13 -- BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 22 April 2013 at 9:00 a.m.Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has started launching Selincro™ in the first European markets, ...

Alle Meldungen von Biotie Therapies Oyj